Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Label
YMAB: Y-mAbs Therapeutics, Inc
2020-10-14 09:00:10
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody
2020-10-14 09:00:10
Y-mAbs Announces FDA Clearance of IND for its Lutetium-177 Labeled Omburtamab Antibody
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.